Europe Genomics In Cancer Care Market Size, Share & Trends Analysis Report By Application, By Product (Instruments, Consumables, Services), By Technology, By Country and Growth Forecast, 2024 - 2031

Analysis of Market Size & Trends

The Europe Genomics In Cancer Care Market would witness market growth of 15.5% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Genomics In Cancer Care Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $3,939.1 million by 2031. The UK market is exhibiting a CAGR of 14.5% during (2024 - 2031). Additionally, The France market would experience a CAGR of 16.4% during (2024 - 2031).

Genomic information allows for the personalization of chemotherapy regimens based on the genetic profile of the patient and the tumor. By identifying genetic variations that affect drug metabolism and efficacy, clinicians can tailor chemotherapy protocols to improve treatment effectiveness and reduce adverse effects, ensuring that each patient receives the most appropriate drugs.

Additionally, adoption of genomics in cancer care has significantly transformed the oncology landscape, driven personalized treatment approaches, and improved patient outcomes. Genomics is increasingly integrated into standard clinical practice as part of routine cancer care.

The high cancer rates in Europe lead to increased government funding and support for cancer research programs. European governments allocate more resources towards genomic research initiatives to understand cancer genomics and develop new treatments. Among the EU countries, the share of deaths from cancer in the total number of deaths in 2021 reached or exceeded 26.0 % in Denmark (28.2 %), Ireland (27.7 %), Slovenia (27.1 %) and the Netherlands (26.6 %). This share peaked at 30.7 % among males in Slovenia, followed by 29.5 % in Denmark.

Free Valuable Insights: The Global Genomics In Cancer Care Market will Hit USD 53.5 Billion by 2031, at a CAGR of 15.7%

Based on Application, the market is segmented into Diagnostics, Personalized Medicine, Drug Discovery & Development, and Research. Based on Product, the market is segmented into Instruments, Consumables, Services. Based on Technology, the market is segmented into PCR, Genome Sequencing, Microarrays, Nuclei Acid Extraction & Purification, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• Agilent Technologies, Inc.
• F.Hoffmann-La Roche Ltd.
• Danaher Corporation (Beckman Coulter, Inc.)
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• GE HealthCare Technologies, Inc.
• Quest Diagnostics Incorporated
• Revvity, Inc.
• Eurofins Scientific SE
• Hologic, Inc.

Europe Genomics In Cancer Care Market Report Segmentation

By Application

• Diagnostics
• Personalized Medicine
• Drug Discovery & Development
• Research

By Product

• Instruments
• Consumables
• Services

By Technology

• PCR
• Genome Sequencing
• Microarrays
• Nuclei Acid Extraction & Purification
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe